Diagnosis and monitoring of renal osteodystrophy

Current Opinion in Nephrology and Hypertension

Volumn 9, Issue 6, 2000, Pages 675-681

  Roe, Simon ^a   Cassidy, Michael J D ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; BIOLOGICAL MARKER; CALCITRIOL; CALCIUM PHOSPHATE; PARATHYROID HORMONE; VITAMIN D;

BONE BIOPSY; BONE DENSITY; BONE TURNOVER; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; KIDNEY FAILURE; OSSIFICATION; OSTEOLYSIS; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RENAL OSTEODYSTROPHY; REVIEW;

ALUMINUM; BIOLOGICAL MARKERS; BIOPSY; BONE AND BONES; BONE RESORPTION; DENSITOMETRY, X-RAY; HUMANS; OSTEOGENESIS; PARATHYROID HORMONE; RENAL OSTEODYSTROPHY; ULTRASONOGRAPHY; VITAMIN D;

EID: 0033693510     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200011000-00014     Document Type: Review

References (54)

1. Renal bone disease 1990: An unmet challenge for the nephrologist
2. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy
3. Low bone turnover in patients with renal failure
4. Uremic bone disease: Advances over the last 30 years
5. Relative hypoparathyroidism and adynamic bone disease
6. Calcific uremic arteriolopathy in association with low turnover uremic bone disease
7. Coronary-artery calcification in young adults with end-stage renaldisease who are undergoing dialysis
8. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
9. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients
10. Circulating biochemical markers of bone remodeling in uremic patients
11. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients
12. Biochemical markers of bone turnover
13. Bone alkaline phosphatase isoenzyme in renal osteodystrophy
14. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients
15. A new assay method that detects only intact osteocalcin. Two-step non-invasive diagnosis to predict adynamic bone disease in haemodialysed patients
16. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis
17. Biochemical markers for noninvasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis
18. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease
19. Bone disease in predialysis, hemodialysis, and CAPD patients. Evidence of a better bone response to PTH
20. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity
21. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure
22. A novel mechanism for skeletal resistance in uraemia
23. Vitamin D deficiency afflicts the majority of patients with end-stage renal disease (ESRD)
24. How important is vitamin D deficiency in uraemia?
25. Apparent nonnuclear regulation of intestinal phosphate transport: Effects of 1,25-dihydroxyvitamin D3, 24,25-dihydroxyvitamin D3, and 25-hydroxyvitamin D3
26. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
27. Importance of vitamin D repletion in uraemia
28. Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients
29. Low serum aluminum values in dialysis patients with increased bone aluminum levels
30. Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload
31. Renal bone disease: Radiological investigation
32. Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism
33. Pathogenesis of secondary hyperparathyroidism
34. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients
35. Presence of sonographically detectable parathyroid glands can predict resistance to oral pulsed-dose calcitriol treatment of secondary hyperparathyroidism
36. Non-invasive measurements of bone mass in adult renal osteodystrophy
37. Bone densitometry: Patients with end-stage renal disease
38. Prevalence and risk factors for osteopenia in dialysis patients
39. Risk factors for reduced bone density in haemodialysis patients
40. Changes in bone mineral density at various sites in patients on hemodialysis due to chronic glomerulonephritis
41. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure
42. Loss of regional bone mineral density in the first 12 months following renal transplantation
43. Rapid loss of vertebral mineral density after renal transplantation
44. Changes in bone mass early after kidney transplantation
45. Long-term bone loss in kidney transplant recipients: A cross-sectional and longitudinal study
46. The epidemiology of quantitative ultrasound: A review of the relationships with bone mass, osteoporosis and fracture risk
47. Quantitative ultrasound of phalanges and dual-energy X-ray absorptiometry of forearm and hand in patients with end-stage renal failure treated with dialysis
48. Quantitative ultrasound in the assessment of skeletal status in uremic patients
49. Usefulness of quantitative heel ultrasound compared with dual-energy X-ray absorptiometry in determining bone mineral density in chronic haemodialysis patients
50. Broadband ultrasound attenuation of the calcaneus. A tool for assessing bone status in patients with chronic renal failure
51. Outpatient percutaneous biopsy of the iliac crest: Methods, morbidity, and patient acceptance
52. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee
53. The role of bone biopsy in clinical practice and research
54. Histological diagnosis of renal osteodystrophy